J9003 HCPCS Level II code: Leuprolide injectable (camcevi etm), 1 mg
J9003 is the HCPCS code for “Leuprolide injectable (camcevi etm), 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9003Leuprolide injectable (camcevi etm), 1 mg
Short description: Leupro inj, camcevi etm, 1mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J9003 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care
- BETOS category
- Chemotherapy
- Added
- Apr 1, 2026
Where J9003 sits
- 1J codesDrugs administered other than orally
- 2Active code J9003Leuprolide injectable (camcevi etm), 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9003 mean?
J9003 is the HCPCS code for “Leuprolide injectable (camcevi etm), 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9003?
CMS lists J9003’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9003
All J codesJ8655Netupitant 300 mg and palonosetron 0.5 mg, oralJ8670Rolapitant, oral, 1 mgJ8700Temozolomide, oral, 5 mgJ8705Topotecan, oral, 0.25 mgJ8999Prescription drug, oral, chemotherapeutic, nosJ9000Injection, doxorubicin hydrochloride, 10 mgJ9010Injection, alemtuzumab, 10 mgJ9011Injection, datopotamab deruxtecan-dlnk, 1 mgJ9015Injection, aldesleukin, per single use vialJ9017Injection, arsenic trioxide, 1 mgJ9019Injection, asparaginase (erwinaze), 1,000 iuJ9020Injection, asparaginase, not otherwise specified, 10,000 units